Private equity firm Cinven has raised its fifth buyout fund, at €5bn.
The Fifth European Buyout Fund is 14% committed, following investments in:
– Mercury Pharma and Amdipharm (healthcare);
– Prezioso (business services) and
– Pronet (business services).
Founded in 1977, Cinven is a private equity firm with offices in Guernsey, London, Frankfurt, Paris, Milan, Luxembourg and Hong Kong. It acquires European-based companies that require an equity investment of €100m or more. Cinven focuses on six sectors Business Services, Consumer, Financial Services, Healthcare, Industrials, and Technology, Media and Telecommunications (TMT).